Kinnate Biopharma Total Assets

Kinnate Biopharma (KNTE) currently reports a total assets of $170M as of December 2023. That compares with $280M in the prior-year period — down 37.7% year over year. Use the charts on this page to explore Kinnate Biopharma's total assets history and peer comparisons.

Kinnate Biopharma's total assets decreased from $280M to $170M — a 37.7% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kinnate Biopharma reported $170M in total assets as of December 2023. That compares with $280M in the prior-year period — down 37.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kinnate Biopharma, and consider following KNTE for alerts when major investors trade the stock.

Kinnate Biopharma is classified in the Healthcare sector. On total assets, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KNTE with unrelated industries.